Clin Ther 2016 Jan 22

Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in a Developing Country.

Eskazan AE1.
href="/pubmed/?term=Eskazan%20AE%5BAuthor%5D&cauthor=true&cauthor_uid=26811186">Eskazan AE1.

Author information

PMID:
26811186
[PubMed - as supplied by publisher]

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk